Administration of oral charcoal adsorbent (AST-120) suppresses low-turnover bone progression in uraemic rats

Nephrology Dialysis Transplantation

Volumn 21, Issue 10, 2006, Pages 2768-2774

  Iwasaki, Yoshiko ^a   Yamato, Hideyuki ^b   Nii Kono, Tomoko ^c   Fujieda, Ayako ^b   Uchida, Motoyuki ^b   Hosokawa, Atsuko ^b   Motojima, Masaru ^d   Fukagawa, Masafumi ^c  

^a OITA UNIVERSITY OF NURSING AND HEALTH SCIENCES   (Japan)

^b KUREHA CORPORATION   (Japan)

^c KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Indoxyl sulphate; Low bone turnover; Oral charcoal adsorbent; Renal failure; Uraemic toxins

Indexed keywords

ALKALINE PHOSPHATASE; AST 120; CHARCOAL; INDICAN; MESSENGER RNA; OSTEOCALCIN; PARATHYROID HORMONE RECEPTOR; PARATHYROID HORMONE RELATED PROTEIN RECEPTOR; UREMIC TOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; BONE TURNOVER; CONTROLLED STUDY; DOWN REGULATION; DRUG ACTIVITY; GENE EXPRESSION; KIDNEY DYSFUNCTION; KIDNEY FAILURE; MALE; MORPHOMETRICS; NONHUMAN; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIBIA; UREMIA; URINALYSIS;

ADMINISTRATION, ORAL; ALKALINE PHOSPHATASE; ANIMALS; BONE AND BONES; CALCIUM; CARBON; CHARCOAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CREATINE; GENE EXPRESSION; INDICAN; MALE; ORGANIC ANION TRANSPORTERS, SODIUM-INDEPENDENT; OSTEOBLASTS; OSTEOGENESIS; OXIDES; PARATHYROID HORMONE; PHOSPHORUS; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIBIA; UREMIA;

EID: 33749611047     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl311     Document Type: Article

References (20)

1. Vanholder R, Smet RD, Glorieux G et al. Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 2003; 63: 1934-1943
2. Niwa T, Yazawa T, Ise M et al. Inhibitory effect of oral sorbent on accumulation of albumin-bound indoxyl sulphate in serum of experimental uremic rats. Nephron 1991; 57: 84-88
3. Niwa T. Textbook of Nephrology, 4th edn. Lippincott, Williams and Wilkins, Baltimore, 2000; 1269-1272
4. Niwa T, Aoyama I, Takayama F et al. Urinary indoxyl sulphate is a clinical factor that affects the progression of renal failure. Miner Electrolyte Metab 1999; 25: 118-122
5. Niwa T, Ise M, Miyazaki T. Progression of glomerular sclerosis in experimental uremic rats by administration of indole, a precursor of indoxyl sulphate. Am J Nephrol 1994; 14: 207-212
6. Niwa T, Ise M. Indoxyl sulphate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis. J Lab Clin Med 1994; 124: 96-104
7. Niwa T, Nomura T, Sugiyama S et al. The protein metabolite hypothesis, a model for the progression of renal failure: An oral sorbent lowers indoxyl sulphate levels in undialyzed uremic patients. Kidney Int 1997; 62 [Suppl 62]: S23-S28
8. Tsubakihara Y, Takabatake Y, Oka K et al. Effect of the oral adsorbent AST-120 on tryptophan metabolism in uremic patients. Am Kidney Dis 2003; 41 [3 Suppl 1]: S38-S41
9. Yorioka N, Ito T, Masaki T et al. Dose-dependent effect of an oral absorbent, AST-120, in patients with early chronic renal failure. J Int Med Res 2002; 30: 467-475
10. Niwa T, Miyazaki T, Hashimoto N et al. Suppressed serum and urine levels of indoxyl sulphate by oral sorbent in experimental uremic rats. Am J Nephrol 1992; 12: 201-206
11. Kobayashi N, Maeda A, Horikoshi S et al. Effect of oral adsorbent AST-120 (Kremezin) on renal function and glomerular injury in early-stage renal failure of subtotal nephrectomized rats. Nephron 2002; 91: 480-485
12. Okada K, Matsumoto K, Takahashi S. Uremic toxins adsorbed by AST-120 promotes tubular hypertrophy and interstitial fibrosis in nephrectomized rats. Kidney Blood Press Res 2005; 28: 8-13
13. Iwasaki-Ishizuka Y, Yamato H, Nii-Kohno T et al. Down-regulation of parathyroid hormone receptor gene expression and osteoblastic dysfunction associated with skeletal resistance to parathyroid hormone in a rat model of renal failure with low turnover bone. Nephrol Dial Transplant 2005; 20: 1904-1911
14. Motojima M, Hosokawa A, Yamato H et al. Uremic toxins proximal tubular injury via organic anion transpoter-1-mediated uptake. Br J Pharmacol 2002; 135: 555-563
15. Enomoto A, Takeda M, Tojo A et al. Role of organic anion transporters in the tubular transport of indoxyl sulphate and the induction of its nephrotoxicity. J Am Soc Nephrol 2002; 13: 1711-1720
16. Motojima M, Hosokawa A, Yamato H et al. Uremic toxins of organic anions up-regulate PAI-1 expression by induction of NF-κB and free radical in proximal tubular cells. Kidney Int 2003; 63: 1671-1680
17. Deguchi T, Kusuhara H, Takedate A et al. Characterization of uremic toxin transport by organic anion transporters in kidney. Kidney Int 2004; 65: 162-174
18. Deguchi T, Kouno Y, Terasaki T et al. Differential contributions of rOat1 (Slc22a6) and rOat3 (Slc22a8) to the in vivo renal uptake of uremic toxins in rats. Pharm Res 2005; 22: 619-627
19. Disthabanchong S, Hassan H, Charles L et al. Regulation of PTH 1 receptor expression by uremic ultrafiltrate in UMR-106-01 osteoblast-like cells. Kidney Int 2004; 65: 897-903
20. Steddon SJ, McIntyre CW, Schroeder NL et al. Impaired release of interleukin-6 from human osteoblastic cells in the uraemic milieu. Nephrol Dial Transplant 2004; 19: 3078-3083